| Literature DB >> 24903262 |
Anne Thushara Matthias1, Niroshan C Lokunarangoda, Ruvan Ekanayaka.
Abstract
BACKGROUND: Cardiovascular Disease (CVD) is a major cause of mortality worldwide. Control and reduction of cardiovascular risk factors such as elevated blood pressure, high cholesterol levels, excess of body weight, smoking and lack of exercise can contribute to a reduction of CVD mortality.Entities:
Mesh:
Year: 2014 PMID: 24903262 PMCID: PMC4057928 DOI: 10.1186/1472-6920-14-113
Source DB: PubMed Journal: BMC Med Educ ISSN: 1472-6920 Impact factor: 2.463
Demographic data
| | |
| Male | 66(50) |
| Female | 66(50) |
| | |
| <30 | 32(24) |
| 30-40 | 71(54) |
| >40 | 17(13) |
| | |
| Anuradhapura | 4(3) |
| Colombo North Teaching Hospital | 1(0.7) |
| Colombo South Teaching Hospital | 9(6.8) |
| Matara | 5(3.7) |
| National Hospital of Sri Lanka (NHSL) | 86(65.1) |
| Peradeniya | 1(0.7) |
| Sri Jayewardenepura General Hospital | 4(3) |
| Jaffna | 5(3.7) |
| Kandy | 1(0.7) |
| Karapitiya | 17(12.8) |
| | |
| <3 years | 51(38.7) |
| 4-6 | 43(32.5) |
| 7-9 | 7(5.3) |
| 10-13 | 29(21.9) |
| 14-16 | 1(0.7) |
| | |
| No training | 56(42.4) |
| <1 year | 47(35.6) |
| 1- 4 years | 20(15.15) |
| >4 years | 9(6.8) |
| | |
| Inter medical officer | 26(19.6) |
| Medical officer | 66(0.5) |
| Registrar | 30(22.72) |
| Senior registrar | 11(8.3) |
Data on secondary prevention
| | |
| Routine clinic visits | 85(65%) |
| Public awareness day seminars | 30(22.2%) |
| Visits to General practioners | 15(11.1%) |
| Consultations with consultant cardiologists | 3(2.2%) |
| Mean(Standard deviation) | |
| Adverse effects of drugs | 2.51(1.10) |
| Patient adherence | 3.44(1.15) |
| Presence of co-morbid conditions | 3.68(0.97) |
| Cost of medications | 3.69(0.97) |
| Too many drugs | 3.74(0.98) |
| Poor knowledge/understanding of patients | 3.82(1.06) |
| Not enough time | 2.76(1.23) |
| Lack of knowledge of doctor | 2.58(1.15) |
| Recommendation on prevention are unclear | 2.62(1.00) |
| Receive little or no training in prevention | 2.96(1.10) |
| Not interested in prevention | 3.07(1.21) |
| Value acute care more than preventive care | 3.25(1.26) |
| Number(Percentage) | |
| Research papers | 42(31.1) |
| Guidelines | 95(70.4) |
| CME | 51(37.8) |
| Consultations with specialists | 49(36.3) |
Knowledge on secondary prevention and knowledge among those who has training versus those who did not have training in cardiology
| | | | | |
| Ask about tobacco use status at the initial visit | 128(94.8) | 53 | 73 | 0.657 |
| Advise every tobacco user to quit | 124(91.9) | 51 | 71 | 0.069 |
| Assist by counseling and developing a plan for quitting or pharmacotherapy (including nicotine replacement and bupropion) | 53(39.3) | 16 | 36 | 0.068 |
| Arrange follow up, referral to special programs | 52(38.5) | 27 | 25 | 0.068 |
| Questions regarding passive exposure to smoke | 70(51.9) | 30 | 39 | 0.856 |
| | | | | |
| What is the systolic blood pressure (SBP) target for patients without Diabetes mellitus (DM) or Chronic kidney disease (CKD) | 60(44.47) | 23 | 36 | 0.593 |
| What is the DBP target for patients without DM or CKD | 53(39.3) | 22 | 30 | 0.716 |
| What is the target for patients with DM or CKD | 60(44.4) | 21 | 39 | 0.365 |
| What is the target for patients with DM or CKD | 18(13.3) | 23 | 41 | 0.366 |
| | | | | |
| What is the goal of low density lipoproteins (LDL) for secondary prevention? | 55(40.7) | 23 | 31 | 0.090 |
| What is the goal of non high density cholesterol (HDL) cholesterol if triglyceride (TG) > 200 mg/dl? | 14(10.4) | 3 | 11 | 0.090 |
| What is the goal of non high density cholesterol (HDL) if triglyceride (TG) > 200 mg/dl? | 18(13.3) | 7 | 11 | 0.254 |
| What is the dose of Atorvastatin you would prescribe? | 0 | 10 | 11 | 0.354 |
| 40 mg | 0 | 0 | 0 | 0 |
| 80 mg | | | | |
| What is the level of TG at which you would initiate therapy with Niacin/Fibrate before statin? | 21(15.6) | 9 | 12 | 0.270 |
| | | | | |
| How much of fat can an average adult take for a day in grams? | 4(3) | 0 | 0 | 0.562 |
| What is the % of polyunsaturated fatty acids (PUFA) out of total fat intake? | 14(10.4) | 4 | 9 | 0.393 |
| What is the % of monounsaturated fatty acids (MUFA) | 8(5.9) | 0 | 0 | 0.007 |
| What is the % of Saturated fatty acids? | 12(8.9) | 2 | 6 | 0.465 |
| What is the amount of recommended daily salt intake in grams/teaspoons? | 37(27.4) | 14 | 22 | 0.561 |
| | | | | |
| What is the amount of alcohol which is safe to consume for men? | 49(36.3) | 4 | 15 | 0.000 |
| What is the amount of alcohol which is safe to consume for women? | 51(37.8) | 2 | 16 | 0.000 |
| | | | | |
| What is frequency of exercise per week? | 40(29.6) | 27 | 27 | 0.214 |
| What is the duration per session? | 79(58.5) | 34 | 56 | 0.089 |
| | | | | |
| What is the optimal waist circumference for men? | 33(24.5) | 18 | 15 | 0.578 |
| What is the optimal waist circumference for women? | 28(20.7) | 15 | 15 | 0.157 |
| What is the goal of HBA1c? | | | | |
| 6.9 | 1(0.7) | 1 | 0 | 0.520 |
| 7 | 62(45.9) | 32 | 30 | 0.217 |
| | | | | |
| Is ACEI indicated in all patients with EF < 40% with no contraindication? | 89(65.9) | 33 | 56 | 0.652 |
| Would you prescribe beta blockers to all patients after ACS if there are no contraindications? | 113(83.7) | 44 | 68 | 0.483 |
| Aspirin duration after an episode of acute coronary syndrome | 83(61.5%) | 40 | 57 | 0.654 |
| Aspirin dose after an episode of acute coronary syndrome | 99(73.4%) | 28 | 53 | 0.088 |
| Clopidogrel dose after an episode of acute coronary syndrome | 100(74%) | 38 | 61 | 0.073 |
| Clopidogrel duration after an episode of acute coronary syndrome | 29(21.5%) | 5 | 5 | 0.074 |